Your browser doesn't support javascript.
loading
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.
Karzai, Fatima; Walker, Stephanie M; Wilkinson, Scott; Madan, Ravi A; Shih, Joanna H; Merino, Maria J; Harmon, Stephanie A; VanderWeele, David J; Cordes, Lisa M; Carrabba, Nicole V; Bright, John R; Terrigino, Nicolas T; Chun, Guinevere; Bilusic, Marijo; Couvillon, Anna; Hankin, Amy; Williams, Monique N; Lis, Rosina T; Ye, Huihui; Choyke, Peter L; Gulley, James L; Sowalsky, Adam G; Turkbey, Baris; Pinto, Peter A; Dahut, William L.
Afiliação
  • Karzai F; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Walker SM; Molecular Imaging Program, NCI, NIH, Bethesda, Maryland.
  • Wilkinson S; Laboratory for Genitourinary Cancer Pathogenesis, NCI, NIH, Bethesda, Maryland.
  • Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Shih JH; Division of Cancer Treatment and Diagnosis, Biometric Research Program, NCI, NIH, Rockville, Maryland.
  • Merino MJ; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland.
  • Harmon SA; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, Maryland.
  • VanderWeele DJ; Laboratory for Genitourinary Cancer Pathogenesis, NCI, NIH, Bethesda, Maryland.
  • Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Carrabba NV; Laboratory for Genitourinary Cancer Pathogenesis, NCI, NIH, Bethesda, Maryland.
  • Bright JR; Laboratory for Genitourinary Cancer Pathogenesis, NCI, NIH, Bethesda, Maryland.
  • Terrigino NT; Laboratory for Genitourinary Cancer Pathogenesis, NCI, NIH, Bethesda, Maryland.
  • Chun G; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Couvillon A; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Hankin A; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Williams MN; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Lis RT; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Ye H; Department of Pathology, Ronald Reagan UCLA Medical Center, Los Angeles, California.
  • Choyke PL; Molecular Imaging Program, NCI, NIH, Bethesda, Maryland.
  • Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Sowalsky AG; Laboratory for Genitourinary Cancer Pathogenesis, NCI, NIH, Bethesda, Maryland.
  • Turkbey B; Molecular Imaging Program, NCI, NIH, Bethesda, Maryland.
  • Pinto PA; Urologic Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Dahut WL; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. dahutw@mail.nih.gov.
Clin Cancer Res ; 27(2): 429-437, 2021 01 15.
Article em En | MEDLINE | ID: mdl-33023952
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Imageamento por Ressonância Magnética Multiparamétrica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Imageamento por Ressonância Magnética Multiparamétrica Idioma: En Ano de publicação: 2021 Tipo de documento: Article